<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="433660" id="root" date="1997-03-11" xml:lang="en">
<title>USA: ADR REPORT - Glaxo hits N.Y. high.</title>
<headline>ADR REPORT - Glaxo hits N.Y. high.</headline>
<dateline>NEW YORK 1997-03-11</dateline>
<text>
<p>British drug company Glaxo Wellcome Plc rose to a 12-month record in New York on Tuesday, boosted by results and ratings upgrades.</p>
<p>Traders said American Depositary Receipts (ADRs) in European companies were seeing revived interest from U.S. buyers who had been evaluating their holdings after a run-up at the start of the year.</p>
<p>&quot;I think people are coming back in, but they are picking companies now and not countries and sectors,&quot;  a trader said. He added that ADRs were being helped by overall rises in their home markets.  </p>
<p>Glaxo rose one to 37-3/8, a 12-month high, in moderate volume.  The company posted strong 1996 results last week and was upgraded by Smith Barney and by Donaldson Lufkin &amp; Jenrette on Monday to outperform from underperform.</p>
<p>The pharmaceutical company also was helped by news Sweden had given it approval to market Naramig, a treatment for migraine headaches.</p>
<p>Among other European ADRs, Swedish telecommunications equipment maker LM Ericsson fell 5/8 to 35-1/2.  </p>
<p>Analysts have speculated the $2.43 billion merger of Newmont Mining Corp and Santa Fe Pacific Gold Corp will lead to a new wave of takeovers among North American gold mining companies.</p>
<p>Brazilian state telephone company Telebras fell 7/8 to 106-1/8.</p>
<p>Decliners led advancers by 231 to 212 among 806 ADRs. Volume was 22 million shares in late morning.</p>
<p>((--Ian Simpson, Wall Street desk, (212) 859-1879))</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-11"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I21000">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-11"/>
  </code>
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-11"/>
  </code>
  <code code="I34400">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-11"/>
  </code>
  <code code="I79020">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-11"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C15">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-11"/>
  </code>
  <code code="C152">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-11"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-11"/>
  </code>
  <code code="M11">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-11"/>
  </code>
  <code code="MCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-03-11"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-03-11"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-03-11"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="NEW YORK"/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
